Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Visterra Inc.
DescriptionHumanized mAb targeting a conserved region on the dengue virus domain III of the E protein
Molecular Target Dengue virus envelope protein E (DENV_gp1)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationDengue fever
Indication DetailsTreat dengue virus infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
Get a free BioCentury trial today